Memorial Sloan Kettering Cancer Center (MSK) is one of the worlds premier cancer centers, committed to exceptional patient care, leading-edge research, and superb educational programs. The blending of research with patient care is at the heart of everything we do. The institution is a comprehensive cancer center whose purposes are the treatment and control of cancer, the advancement of biomedical knowledge through laboratory and clinical research, and the training of scientists, physicians and other health care workers.

Postdoctoral fellow and research associate positions are available for highly motivated individuals interested in studying the BCL-2 family and cell death mechanisms, translating cell death mechanisms into targeted cancer therapy, interrogating the impact of cell death on tumor-immune crosstalk and immunotherapy, and exploiting immunogenic cell death to improve immunotherapy (Science 330: 1390-1393; Cancer Cell 39: 1245-1261; Nature Cancer 2022, doi: 10.1038/s43018-021-00316-3; Molecular Cell 36: 487-499; Nature Cell Biology 8: 1348-1358; Nature Cell Biology 17: 1270-1281; Nature Communications 7: 13131;). We are particularly interested in targeted therapy and immunotherapy of lung and kidney cancers.

The ideal candidate should have:

• Ph.D. degree
• Strong background in cancer biology, immunology, and mouse models
• Good publication record

Full applications including curriculum vitae and a list of three references should be submitted via email to:

chengpostdocapps@gmail.com

Emily Cheng, M.D., Ph.D.

Member & Professor, Human Oncology and Pathogenesis Program

Memorial Sloan Kettering Cancer Center

1275 York Avenue, Box 20

New York, NY 10065, USA

#LI-POST